BackLB PharmaceuticalsCommon Stock Overview
LB Pharmaceuticals Inc Common Stock

LB PharmaceuticalsCommon Stock Target Price

Where could LBRX trade next? Consensus target price: $53.

Get informed when a big investor buys or sells

+ Follow

Share Price

$44.63

Average Target Price

$53.2919.4% upside

7 analysts in the last 4 months

High: $78 | Low: $37

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-24H.C. WainwrightRaghuram Selvaraju$6034.4% upsideOpen
2026-08-13Stifel Nicolaus$5318.8% upsideOpen
2026-08-12BMO Capital$5421% upsideOpen
2026-08-03Piper SandlerYasmeen Rahimi$7874.8% upsideOpen
2026-07-20BMO Capital$463.1% upsideOpen
2026-07-07Wolfe ResearchRudy Li$450.8% upsideOpen
2026-05-17Roth Capital$3717.1% downsideOpen
2026-04-27H.C. Wainwright$450.8% upsideOpen
2026-04-10Craig-Hallum$3619.3% downsideOpen
2026-03-27Stifel Nicolaus$4010.4% downsideOpen
2026-01-09Roth Capital$3130.5% downsideOpen
2025-12-11Stifel Nicolaus$3521.6% downsideOpen
2025-10-06Leerink Partners$3423.8% downsideOpen
2025-10-06Stifel Nicolaus$2739.5% downsideOpen

LB PharmaceuticalsCommon Stock (LBRX) FAQ

LB PharmaceuticalsCommon Stock (LBRX) currently reports a target price of $53. Use the charts on this page to explore LB PharmaceuticalsCommon Stock's target price history and peer comparisons.

Analysts' average 12-month price target for LB PharmaceuticalsCommon Stock is $53, about 19.4% upside from the current share price of $44.63. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $53, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for LB PharmaceuticalsCommon Stock, and consider following LBRX for alerts when major investors trade the stock.

LB PharmaceuticalsCommon Stock is classified in the Healthcare sector. On target price, it currently shows $53. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LBRX with unrelated industries.